Important Clarification & Product Assessment (English):

The product name "EBAGET-D 20mg Tablets" suggests a dual-antihistamine formulation. However, based on standard pharmacological principles and regulatory approvals:

1. ✅ Ebastine is commonly available in 10mg and 20mg strengths.
2. ✅ Desloratadine is only approved in a single dose of 5mg for adults—not 20mg.

Therefore, "EBAGET-D 20mg" most likely contains:

✅ Ebastine 20mg

✅ Desloratadine 5mg

The "20mg" in the name refers to the ebastine component, not desloratadine. This is consistent with naming conventions in Pakistan, where the higher-numbered antihistamine dose is used in the product title.

📌 Note: Dual antihistamine combinations (e.g., ebastine + desloratadine) are not standard first-line therapy per international guidelines but are marketed in some countries like Pakistan for refractory allergic conditions.

Product Full Description (English):

Active Ingredients:

1. Ebastine 20mg
2. Desloratadine 5mg

Uses:

1. Symptomatic relief of severe or refractory allergic rhinitis (seasonal/perennial)
2. Management of chronic idiopathic urticaria unresponsive to single antihistamine therapy
3. Relief from allergic conjunctivitis, pruritus, and angioedema (adjunctive)

Key Benefits:

1. Enhanced H1-receptor blockade for superior symptom control
2. Non-sedating profile (minimal CNS penetration)
3. Once-daily dosing convenience
4. Desloratadine provides additional anti-inflammatory effects (inhibits leukotrienes, cytokines)

How To Use:

Take one tablet once daily, with or without food. Swallow whole with water. Use only as directed—typically for short-term flare-ups or under specialist supervision.

When Not to Use:

1. Hypersensitivity to ebastine, desloratadine, or excipients
2. Severe hepatic impairment (both drugs are hepatically metabolized)
3. History of QT prolongation or cardiac arrhythmias (ebastine 20mg may rarely affect conduction)
4. Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin, grapefruit juice)

Side Effects:

Common: Headache, dry mouth, fatigue, mild drowsiness, nausea.

Rare: Insomnia, palpitations, abdominal discomfort.

Serious (very rare): QT interval prolongation, hypersensitivity reactions.

Discontinue if cardiac symptoms (palpitations, dizziness) or severe rash occur.

Dosage:

1. Adults & adolescents (≥12 years): One tablet once daily
2. Maximum duration: Short-term use (≤7–10 days) unless prescribed otherwise
3. Not for children under 12 years

Who It’s For:

Adults with severe, persistent allergies or hives not controlled by standard antihistamines. Not for mild symptoms or first-line use.

Warnings & Precautions:

1. Avoid in patients with liver disease or cardiac risk factors
2. May cause drowsiness in sensitive individuals—avoid driving if affected
3. Not a substitute for epinephrine in anaphylaxis

Drug Interactions:

1. CYP3A4 inhibitors: ↑ Ebastine levels → potential QT prolongation
2. CNS depressants: Possible additive sedation (rare)
3. Always disclose all medications to your doctor.

Additional Information:

Store below 30°C in a dry place, protected from light. Keep out of reach of children. Do not use after expiration date. Available over-the-counter or by prescription in Pakistan.